News Release
| Reference |
 |
 |
|
1. Fluorescence Molecular Tomography (FMT) System |
 |
| Fluorescence Molecular Tomography (FMT) system |
|
| VisEn’s Fluorescence Molecular Tomography (FMT) system represents a breakthrough in optical molecular imaging by enabling true quantification and tomographic reconstruction of fluorochrome concentration and distribution at any depth in small animal research models. The system is driven by VisEn’s powerful, comprehensive and easy-to-use FMT software that enables the acquisition and archiving of images, as well as the analysis of fluorochrome concentration and distribution in user-specified three-dimensional regions of interest – all with a standard desktop PC. |
|
| Primary applications of VisEn’s FMT system include detection, monitoring and measurement of disease progression and therapeutic response in various animal models of disease, including oncology, arthritis, and respiratory, cardiovascular and bone disease. |
|
| 2. Near Infrared (NIR) Fluorescence Probes |
 |
| Near Infrared (NIR) Fluorescence Probes |
|
| VisEn’s Near Infrared (NIR) Fluorescence Probes harnesses the power of fluorescent labeling technology for in vivo molecular imaging. Developed for optimal in vivo performance, biocompatibility and ease of use, VisEn’s probes can be used with a variety of optical imaging systems, including VisEn’s FMT systems. The VisEn series of in vivo imaging probes enables a range of imaging readouts on key disease-associated biologic processes, including angiogenesis, protease activity, vascular permeability, inflammation, cell migration and tracking, and bone regeneration. Molecular, compatible, versatile, safe and translatable, VisEn’s probes are ready today for use in your research models. |
|
| CAUTION-Device (VisEn’s Fluorescence Molecular Tomography (FMT) System and VisEn’s Near Infrared (NIR) Fluorescence Probes) for investigational use in laboratory animals or other tests that do not involve human subjects. |
|
 |
*The company names and product names specified in this release are the trademarks or registered trademarks of each company.
Please be advised that press releases and information posted on this site are current at the time of the original publication date. Please note that they may now be outdated or rendered inaccurate.
Contents end
